Qureator is pleased to announce that CEO Dr. Kyu Baek will present the company’s newest innovation—the Vascularized Tumor Immune Microenvironment (vTIME) platform—at the CSEM Next-Gen Organ-on-Chips & Organoids Workshop on February 14th in Basel. Designed to closely replicate human tumor-immune dynamics, the vTIME model enables more predictive and translational immunotherapy development. This presentation marks an exciting opportunity to share Qureator’s vision for advancing human-relevant preclinical research. We look forward to engaging with fellow innovators and collaborators at this leading-edge event!